News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
Skin conditions are among the most common health issues worldwide, impacting millions and posing significant challenges to healthcare...
Each year, on the last day of February, the world comes together to recognize Rare Disease Day, in...
[Sofia, Bulgaria] – An innovative study on antibiotic resistance, featuring contributions from Professor Krasimir Kalinov, Head of the...